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Abstract A purine nucleoside phosphorylase from the
alkaliphile Bacillus halodurans Alk36 was cloned and
overexpressed in Escherichia coli. The enzyme was puri-
ﬁed ﬁvefold by membrane ﬁltration and ion exchange. The
puriﬁed enzyme had a Vmax of 2.03 9 10
-9 s
-1 and a Km
of 206 lM on guanosine. The optimal pH range was
between 5.7 and 8.4 with a maximum at pH 7.0. The
optimal temperature for activity was 70C and the enzyme
had a half life at 60C of 20.8 h.
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Abbreviation
BHPNP1 Bacillus halodurans purine nucleoside
phosphorylase 1
Introduction
5-Methyluridine is a non-natural nucleoside that can be
used as an intermediate in the synthesis of thymidine, and
in the synthesis of nucleoside analogues AZT and stavu-
dine, both of which are used in highly active antiretroviral
treatment of HIV/AIDS patients. As the compound needs
to be formed as a single isomer, 5-methyluridine can be
synthesised through the transglycosylation of D-ribose-1-
phosphate, using guanosine as a donor, and thymine as
receptor (Ge et al. 2009; Medici et al. 2008; Rocchietti
et al. 2004). Enzymes provide regio- and stereoselectivity,
and hence are an ideal option for nucleoside transglyco-
sylation (Prasad et al. 1999; Utagawa 1999). The hydro-
lysis reaction for the ribose decoupling reaction can be
achieved using purine nucleoside phosphorylase (PNPase;
EC 2.4.2.1) (Fig. 1).
However, the reagents guanosine and thymine are rela-
tively insoluble, and are particulate substrates with poor
reaction kinetics. The most effective method of solubilising
these materials is in hot aqueous solutions. Therefore, it
would be preferable to utilise thermostable enzymes to
catalyse these reactions. Enzymes that can be used in this
transglycosylation reaction include PNPase, thymidine
phosphorylase (TPase; EC 2.4.2.4) and uridine phosphor-
ylase (UPase; EC 2.4.2.3) (Bzowska et al. 2000; Pugmire
and Ealick 2002). TPase and UPase are functionally both
pyrimidine nucleoside phosphorylases (PyNPase; EC
2.4.2.2.), although UPase is closer in sequence identity to
PNPase than PyNPase (Lewkowicz and Iribarren 2006).
PNPases are divided into two different classes depending
on their tertiary and quaternary structures (Bzowska et al.
2000). Type I PNPases tend to be bacterial in origin and,
based on sequence and structural information, appear to
have a hexameric structure. Type II PNPases tend to be
found in eukaryotes and, based on the sequence and
structural information, are trimeric in structure (Bzowska
et al. 2000; Pugmire and Ealick 2002). Bzowska et al.
(2000) refer to type I PNPases as high molecular mass
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PNPases on the basis of their quaternary structures
(Bzowska et al. 2000). In general, prokaryotic PNPases are
more amenable to these transglycosylation reactions as
they have broader speciﬁcity than their mammalian coun-
terparts (Tonon et al. 2004). In addition, thermophiles have
been shown to harbour enzymes that exhibit a much greater
thermostability. For example, the thermophile Geobacillus
stearothermophilus (previously Bacillus stearothermophi-
lus) has two purine nucleoside phosphorylases which have
been characterised (Hori et al. 1989a, b; Saunders et al.
1969) and applied in the synthesis of 5-methyluridine (Hori
et al. 1989c, 1991). However, although these enzymes are
thermostable, they have low levels of expression in the
wild type. The genes have both been subsequently suc-
cessfully expressed in E. coli at high levels (Hamamoto
et al. 1996, 1997a, b).
The present work investigated the nucleoside phospho-
rylases present in the moderately thermophilic and alkali-
philic organism Bacillus halodurans Alk36 (Louw et al.
1993; Crampton et al. 2007). This organism was chosen
due to its moderately thermophilic nature. It describes the
cloning, heterologous expression in E. coli, puriﬁcation,
and evaluation of BHPNP1, a purine nucleoside phos-
phorylase from B. halodurans Alk36.
Methods
Materials
All restriction enzymes and the T4-DNA ligase were pur-
chased from Fermentas (Lithuania). The Roche high-
ﬁdelity PCR mix was used for all polymerase chain reac-
tions. SDS-PAGE markers were purchased from
Fermentas.
Bioinformatics
Owing to the high level of sequence identity between the
genomes of B. halodurans Alk36 and B. halodurans C-125
the genome sequence of B. halodurans C-125 (Takami
et al. 2000) (NC_002570), as published in the DNA Data
Bank of Japan (http://gib.genes.nig.ac.jp), was searched for
novel nucleoside phosphorylase gene sequences using the
genomic BLAST (basic local alignment search tool;
Altschul et al. 1990) located at the NCBI to conﬁrm that no
other PNPases or PyNPases were present apart from the
annotated ones. Two PNPase and one PyNPase genes were
identiﬁed. The two PNPases are BH1531 and BH1532, and
the PyNPase was designated BH1533. Primers for the
ampliﬁcation of the PNPase gene BH1531 were designed
based on the genome sequence. Isolation and character-
isation of the gene corresponding to BH1531 from B.
halodurans strain Alk36 was subsequently performed. This
gene was termed BHPNP1.
Genomic DNA isolation
Bacillus halodurans Alk36 was grown overnight at 42Ci n
Luria Broth (LB) pH 8.5 (10 g/L NaCl; 10 g/L tryptone,
5 g/L yeast extract). Genomic DNA was isolated from B.
halodurans according to the method of Lovett and Keggins
(1979).
Cloning of the B. halodurans Alk36 PNPase gene
The PNPase gene designated BHPNP1 was ampliﬁed using
the following primers: BH1531F 50—GGACATATGCTT
AACGTAACTCAATTG (NdeI site, underlined) and
BH1531R 50—GGTAAGCTTTTACATGTCTTTAACGA
TTGC (HindIII site, underlined). PCR was performed
using the high-ﬁdelity polymerase from Roche (Germany).
The PCR ampliﬁcation protocol employed was as follows:
a single 10-min hold at 95C was followed by 25 cycles of
1 min at 95C, 1 min at 55C and 1 min at 72C. A ﬁnal
10-min incubation at 72C was followed by a 4C hold.
The size of the ampliﬁed product was conﬁrmed on a 0.8%
agarose gel and isolated using the Geneclean kit
TM (Qbi-
ogene, USA). The PCR product was ligated into pGEM-T
Easy (Promega, USA). Restriction digests were performed
with NdeI and HindIII to release the BHPNP1 insert.
The BHPNP1 gene was subsequently ligated using T4-
DNA ligase (Fermentas) into the pMS470D8 expression
vector (Balzer et al. 1992) restricted with NdeI and
HindIII. This gave plasmid pMSPNP. This plasmid was
transformed into E. coli JM109 (DE3) for expression
analysis.
Fig. 1 Phosphorolysis of
guanosine by purine nucleoside
phosphorylase
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The insert was sequenced at Inqaba Biotechnology (Pre-
toria, South Africa) using the PCR primers described
above. The sequence was compared with the known
nucleotide and amino acid sequence of the BH1531 gene
from B. halodurans C-125 (protein sequence—BAB05250)
and has been submitted to GenBank under the accession
number GQ390428.
Homology modelling
Multiple sequence alignments were performed using Clu-
stalW (Larkin et al. 2007). Homology modelling was per-
formed using Accelrys Discovery Studio 2.0. A trimeric
model was based on the bovine structure 1LVU (Bzowska
et al. 2004). A second model was based on the monomeric
structure 1VFN (Koellner et al. 1997). Bovine PNPase and
BHPNP1 have 49% sequence identity and 61% sequence
similarity (Table 1).
Growth and induction
Recombinant E. coli strains were grown in 50 ml LB
medium with 100 lg/ml ampicillin, at 37C with shaking
at 200 rpm. Cultures were induced with 0.25 mM IPTG
when they had reached an OD600 between 0.05 and 0.1.
Cultures were subsequently grown at 30C with shaking at
150 rpm overnight for enzyme expression.
Batch fermentations
A 1.5 l InFors HT batch fermentor (Labfors, Switzerland)
containing 1 l of GMO 20 medium was inoculated with a
50 ml inoculum (overnight culture of E. coli JM109
[pMSPNP] in LB medium). The composition of the GMO
20 medium was as follows: 14.6 g/l K2HPO4, 2 g/l
(NH4)2SO4, 3.6 g/l Na2HPO4, 2.5 g/l citric acid, 1.2 g/l
MgSO4, 5 g/l NH4NO3, and 20 g/l yeast extract. Glucose
(17.5 g/l) and trace element solution (5 ml/l) was sterilized
separately and added to the fermenters before inoculation.
Ampicillin (100 lg/ml) was aseptically added to the ﬂasks
containing the glucose and trace element solution. The
trace element solution consisted of the following: 0.4 g/l
CaCl2.2H2O, 16.7 g/l FeCl3.6H2O, 0.15 g/l MnCl2.4H2O,
0.18 g/l ZnSO4.7H2O, 0.125 g/l CuCl2.2H2O. 0.18 g/l
CoCl2.6H2O, and 20.1 g/l Na2EDTA. The pH of the fer-
mentations was controlled at pH 7.2 with 33% m/v NH4OH
or 20% m/v H2SO4. The temperature was controlled at
37C and the aeration set to 1 v/v/m. The starting agitation
was set at 300 rpm and ramped up manually to control the
pO2 above 30% saturation. PNPase expression was induced
at mid-log phase by adding IPTG to a ﬁnal broth concen-
tration of 0.5 mM. Fermentations were run for a further 4 h
after induction.
Preparation of crude extract
After induction, the bacteria were harvested by centrifu-
gation (15,000g, 20 min). The pellet was re-suspended in
minimal sterile deionised water, and subjected to a freeze–
thaw cycle alternating between ?20 and -20C. Liberated
protein was separated by centrifugation (14,000g, 10 min)
and stored. The pellet was re-suspended in 1 l sterile
deionised water and further disrupted using a cell disruptor
(2 Plus, Constant Systems, UK) with 1 pass at 40 kpsi.
Cellular debris was removed by centrifugation (15,000g,
10 min). The resultant protein solution (supernatants from
freeze–thaw and cell disruption processes) were concen-
trated and washed once with sterile deionised water by
ultraﬁltration using an Amicon (Millipore, USA) stirred
cell ultraﬁltration unit (30 kDa cut-off polyethersulfone
membrane). The ﬁnal preparation was lyophilised in the
presence of 1% maltose and 1% PEG 8000 (Vertis Genesis
25 l). A portion of the lyophilised product, equivalent to
200 ml original fermentation broth, was re-suspended in
20 mM Tris–HCl buffer (pH 7.5) for further puriﬁcation.
Column chromatography
Anion exchange chromatography of each sample was
performed on an AKTA Prime (Amersham Biosciences,
Table 1 Comparison of various
PNPases to BHPNP1
Protein Percentage of
protein identity
Percentage of
protein similarity
PNPase
type
Accession
number
E. coli PNP 17.0 33.0 I P0ABP8
E. coli XapA 44.0 61.0 II NP_416902
G. stearothermophilus PNP1 74.9 86.2 II P77834
Bovine PNP 47.1 61.1 II P55859
Human PNP 45.2 58.5 II P00491
B. halodurans BH1532 57.1 75.6 II BAB05251
B. subtilis PNP 69.6 78.8 II P46354
G. stearothermophilus PNP2 18.3 32.2 I P77835
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123UK) using Toyopearl SuperQ650m anion exchange resin
(Tosoh BioSep, USA). Protein was ﬁrst eluted from the
column using a salt gradient of between 50 and 500 mM
NaCl in 20 mM Tris–HCl pH 7.2, over 400 ml at a ﬂow
rate of 4 ml/min. PNPase activity was assayed in all frac-
tions (5 ml fractions collected) and those containing
activity were separately pooled and concentrated by
ultraﬁltration (30 kDa membrane, Millipore USA). This
sample was then re-applied to the anion exchange column
and eluted over a salt gradient of 150–400 mM NaCl.
Active fractions were pooled and concentrated by ultraﬁl-
tration as above.
Tertiary conformation
Denatured (5 min, 95C) and non-denatured preparations
of the enzyme were analysed on a 12% SDS-PAGE gel.
The gel was overlaid with a 0.5% agarose solution to
determine the position of active subunits. The agarose
solution contained 10 mM inosine, 0.2 U/ml xanthine
oxidase and 10 mM INT (iodonitrotetrazolium violet) in
20 mM sodium phosphate buffer, pH 7.5. Active PNPase is
indicated by a red/pink band on the gel due to the cascade
action of the PNPase and xanthine oxidase leading to the
reduction of INT to its tetrazolium salt. Positions of active
and non-active units were then conﬁrmed by staining the
gel with Coomassie brilliant blue G-250.
PNPase assay
A volume (10 ll) of suitably diluted sample was added to
190 ll of 50 mM sodium phosphate buffer containing
0.5 mM inosine and 0.2 U/ml of xanthine oxidase in UV
compatible microtitre plates (Thermomix) (Erion et al.
1997). The change in absorbance at 293 nm due to the
liberation of uric acid was measured on a Powerwave HT
microplate spectrophotometer (Biotek, USA). One unit of
PNPase is deﬁned as the amount of enzyme required to
liberate 1 lmol of uric acid from inosine, in the presence of
an excess of xanthine oxidase, in 1 min. The extinction
coefﬁcient (e) under these conditions was determined to be
7,454 cm
2/mol.
Physical characteristics
A pH proﬁle was performed using reaction mixtures (1 ml)
containing 1 mM guanosine in 50 mM universal buffer
(50 mM Tris, 50 mM boric acid, 33 mM citric acid 50 mM
Na2PO4), adjusted to pH values between 3 and 11 with
either HCl or NaOH. PNPase (0.025 U) was added to ini-
tiate the reaction. After 10 min of incubation at 40C, the
reaction was stopped by the addition of 0.5 ml of a 5 M
NaOH solution. Guanosine conversion and guanine
formation were analysed by HPLC on a Waters 2690 HPLC
(interfaced with Waters Millennium Software) equipped
with Waters 996 Photodiode Array Detector at 260 nm and
a Phenomenex Synergi 4u Max-RP 80A, 150 9 4.60 mm
column at 22C. The mobile phase was 25 mM ammonium
acetate (pH 4.0), at a ﬂow rate of 1.0 ml/min.
The temperature optimum was determined with reaction
mixtures (1 ml) containing 1 mM guanosine in 50 mM
sodium phosphate buffer, pH 8.0. PNPase (0.025 U) was
added to initiate the reaction. After 10 min of incubation at
temperatures between 30C and 90C, the reaction was
stopped by the addition of 0.5 ml of a 5 M NaOH solution.
Guanosine conversion and guanine formation were ana-
lysed by HPLC as above. For temperature stability, enzyme
solutions were incubated at temperatures between 40 and
70C. Samples were removed and analysed every 30 min
for the ﬁrst 2 h, followed by less frequent sampling for a
further 18 h.
Kinetic parameters
The kinetic parameters for PNPase were determined for
both inosine (standard assay) and guanosine (assay as
described for temperature optimum study) as starting sub-
strates. Initial substrate concentrations were varied between
0.05 and 1.0 mM. The reaction was stopped at 1, 2, 3, 4, 6
and 10 min to ensure measurements remained in the linear
range. Michaelis–Menten plots and the linear transforma-
tions (Lineweaver–Burk, Hanes–Woolf and Eadie–Hof-
stee) were used to determine kinetic parameters.
Results and discussion
Sequence analysis and homology modelling
Bacillus halodurans is unusual amongst the Bacilli that
have been completely sequenced so far in that it contains
two type II PNPases as opposed to the types I and II
PNPases present in other Bacillus species (unpublished
data). The gene sequence of BHPNP1 was identical to that
of BH1531 from B. halodurans C-125 except for a silent
substitution at nucleotide 519 (C–T), and hence the protein
sequence was identical to that expressed by B. halodurans
C-125. BLAST analysis indicated that the closest related
structure deposited in the protein data base (PDB) was that
of the bovine PNP (Table 1; Fig. 2) which is 47% identical
to BHPNP1. On the basis of sequence identity, BH1531 is a
member of the type II PNPases.
BHPNP1 has low levels of identity to type I PNPases,
such as E. coli PNP and G. stearothermophilus PNP2 (17
and 18.3% identity, respectively). It has higher levels of
identity to type II PNPases. Selected type II PNPases were
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123aligned using ClustalW (Larkin et al. 2007). Amino acids
known to be involved in the activity of the bovine and
human enzymes (Lewkowicz and Iribarren 2006; Ealick
et al. 1990) were generally conserved, with the exception of
Tyr
192, Ser
234, Met
236 and Ala
237 in BHPNP1 and Cys
115,
Tyr
193, Met
194, Ile
210, Asp
236, Met
237 and Ala
238 in
BH1532. These were all conservative substitutions with the
exception of Met
236 (BHPNP1), Cys
115, Met
194 and Met
237
(BH1532).Theposition andorientation oftheseresiduesare
shown in Fig. 3. Hence, it is likely that the active site, and
overall tertiary structure, of BHPNP1 should resemble the
bovine and human PNPases and is, therefore, likely to be a
homotrimer. The structure of BHPNP1 was, hence, mod-
elled based on the structure of the bovine PNPase (Fig. 3).
This structure shows the modelled monomer, including a
putative substrate, namely hypoxanthine. Residues that are
known to be important in structure and function of the
mammalian proteins and are conserved in BHPNP1 are
indicated in yellow. Residues that are known to be impor-
tant instructure andfunctionofthe mammalian proteinsand
are not conserved in BHPNP1 are indicated in red.
Tertiary conformation
BHPNP1 and G. stearothermophilus PNP1 are 74.9%
identical. These proteins are likely to have similar
structural characteristics. As already mentioned by Ha-
mamoto et al. (1997b), the high level of sequence identity
between the G. stearothermophilus PNP1 and the eukary-
otic PNPases strongly suggest structural similarity. This
would also apply to the BHPNP1 protein. However, gel
ﬁltration analysis of the G. stearothermophilus PNP1 gave
Fig. 2 Multiple sequence
alignment comparing BHPNP1
to other type II PNPases
BHPNP1 was aligned with G.
stearothermophilus PNP1
(P77834) (Hamamoto et al.
1997a), bovine PNP (P55859)
(Bzowska et al. 1995), human
PNP (P00491) (Williams et al.
1984), B. subtilis PNP (P46354)
(Schuch et al. 1999), the second
B. halodurans PNP (BH1532,
BAB05251) (Takami et al.
2000) and E. coli XapA
(NP_416902) (Dandanell et al.
2005). The alignment was
generated using ClustalW
(Larkin et al. 2007;
http://www.ebi.ac.uk/clustalw).
Residues shown to be important
in the binding site of bovine and
human PNPases are underlined
(Mao et al. 1997, 1998; Mont-
gomery et al. 1993; Narayana
et al. 1997). Dots (. and :) indi-
cate partial similarity and
asterisks (*) indicate a 100%
match
Fig. 3 Homology modelled three-dimensional structure of BHPNP1.
Homology modelling of the BHPNP1 structure was performed using
the bovine structure 1VFN (Koellner et al. 1997) as a template. The
monomer was modelled along with the substrate, hypoxanthine
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123an apparent molecular weight of 68,000, potentially indi-
cating a dimeric protein (Hori et al. 1989b).
To conﬁrm whether BHPNP1 is a trimer, which the
sequence data suggests, or a dimer based on information
about G. stearothermophilus PNP1 an overlay experiment
was performed. The stained gel and overlay are shown in
Fig. 4. The experiment indictated that the predominant
tertiary conﬁrmation was a dimer. The expected mono-
meric subunit was visible in both the heat-treated and non-
heat-treated samples at approximately 27 kDa. Another
dominant band at approximately 50 kDa on the Coomassie
stained gel (lane 2, Fig. 4a) was related to the active band
on the overlay (lane 2, Fig. 4b). Hence, in contrast to the
mammalian system, this enzyme appears to be dimeric.
Enzyme expression and puriﬁcation
The productivity of B. halodurans Alk36 BHPNP1 heter-
ologously expressed in E. coli JM109 (DE3) was 700 U/l/h
in shake ﬂasks, but increased to 3,007 U/l/h under the
controlled fermentation conditions. PNPase was puriﬁed to
42% purity (by density analysis in SDS-PAGE, Fig. 5) and
a speciﬁc activity of 30.2 U/mg total protein with a fold
puriﬁcation of 5.0 from the culture broth (Table 2).
Physical characteristics
PNPase showed a pH optimum of 7.0, retaining 60%
activity between pH 5.7 and 7.4 (Fig. 6). PNPase had
optimum activity at 70C and a broad activity range,
retaining 60% activity between 30 and 74C (Fig. 7).
Although the optimum temperature of PNPase was shown
to be 70C, only 7.2% activity remained after 30 min
incubation at this temperature (t1/2 - 15.2 min). PNPase
did, however, show good stability at 60C( t1/2 - 20.8 h)
and excellent stability at 40C, with no change in activity
over the time period (19 h).
Kinetic characterisation
Linear transformation of velocity data obtained for varying
initial substrate concentrations showed good linear
regression ﬁt where inosine was used (R
2[99% for all
plots) and adequate ﬁt for guanosine experiments
(R
2[94%). From the plots (Lineweaver–Burk, Eadie–
Hofstee and Hanes–Woolf), Km and Vmax were determined
with\7% deviation in the values calculated from the three
plots. Subsequently, the turnover number (kcat) and the
speciﬁcity constant were calculated. These values are
summarised in Table 3.
The PNP1 from the thermophile G. stearothermophilus
has been previously expressed and characterised (Hori
et al. 1989a; Hamamoto et al. 1997a). The G. stearother-
mophilus enzyme has a pI of 4.7, with an optimal pH range
between 7.5 and 11, in contrast to the optimal pH range of
BHPNP1 of between 5.7 and 8.4 and a predicted pI of 5.1.
The G. stearothermophilus PNPase is more thermostable
then BHPNP1 as it is stable at 70C for greater then 30 h.
In contrast, the half life of PNPase BHPNP1 at 60Ci s
20 h. G. stearothermophilus PNPase Km for inosine was
similar at 0.22 mM, but had a greater afﬁnity for guanosine
at Km of 0.14 mM.
Fig. 4 12% SDS PAGE gel (a) and corresponding activity gel
overlay (b). M marker, lane 1 heat-treated PNPase preparation (95C,
5 min); lane 2 non-heat-treated PNPase preparation. Arrows indicate
the position of the monomer and the dimer Fig. 5 Denaturing SDS-PAGE gel (12%) showing successive puri-
ﬁcation steps. Various fractions from a puriﬁcation of BHPNP were
resolved using 12% SDS-PAGE. Lane 1 protein marker sizes in
kilodaltons, lane 2 crude extract, lane 3 concentrated sample after
anion exchange column 1, lane 4 ﬁnal sample after anion exchange
column 2
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The thermostable type II nucleoside phosphorylase from the
bacterium B. halodurans Alk36 was expressed heterolo-
gously in E. coli, puriﬁed, and functionally characterised.
The enzyme was capable of phosphorolysis of guanosine to
yield guanine and ribose-1-phosphate, the latter of which
may be used in the enzymatic glycosylation of nucleosides.
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